Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
Showing 1 - 25 of >10,000
Recurrence of Manic and Depressive Episodes in Bipolar Disorder
Recruiting
- Bipolar Disorder
- Depressive Disorder
- Wearable activity tracker
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 13, 2023
Bipolar Disorder Trial in Hangzhou (Repetitive Transcranial magnetic stimulation, Sham Repetitive Transcranial magnetic
Recruiting
- Bipolar Disorder
- Repetitive Transcranial magnetic stimulation
- Sham Repetitive Transcranial magnetic stimulation
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Jun 26, 2023
Abilify Prolonged Release Aqueous Suspension for IM Injection
Recruiting
- Bipolar Disorder I
- Abilify prolonged release aqueous suspension for IM injection (Aripiprazole)
-
Osaka, JapanPharmacovigilance Department
Jan 23, 2023
Bipolar Disorder, Pediatric Trial (asenapine, Placebo to match asenapine, Rescue medication)
Bipolar Disorder, Type 1 Trial in Sao Paulo (Active Theta Burst Stimulation (TBS), Sham Theta Burst Stimulation (TBS))
Active, not recruiting
- Bipolar Disorder, Type 1
- Active Theta Burst Stimulation (TBS)
- Sham Theta Burst Stimulation (TBS)
-
Sao Paulo, BrazilInstitute of Psychiatry, University of Sao Paulo
Aug 12, 2022
Manic Episode Trial in Shanghai (active group of tDCS, sham group of tDCS)
Recruiting
- Manic Episode
- active group of tDCS
- sham group of tDCS
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Nov 13, 2022
Bipolar Disorder Trial (ziprasidone oral capsules)
Withdrawn
- Bipolar Disorder
- ziprasidone oral capsules
- (no location specified)
Feb 18, 2021
Bipolar Disorder Trial (Placebo, Ziprasidone Oral Capsules)
Withdrawn
- Bipolar Disorder
- Placebo
- Ziprasidone Oral Capsules
- (no location specified)
Feb 18, 2021
Bipolar Disorder Trial in United States (Ziprasidone, Placebo)
Bipolar Depression, MDD Trial in Worldwide (Lumateperone, Placebos)
Recruiting
- Bipolar Depression
- Major Depressive Disorder
- Lumateperone
- Placebos
-
Garden Grove, California
- +41 more
Feb 28, 2022
Schizophrenia, Schizotypal Disorder, Delusional Disorder Trial in Munich (Metacognitive and Defusion Training)
Active, not recruiting
- Schizophrenia
- +12 more
- Metacognitive and Defusion Training
-
Munich, Bavaria, GermanyMax Planck Institute of Psychiatry
Aug 23, 2022
Bipolar I Disorder Trial in Long Beach, Atlanta, Marlton (Iloperidone, Iloperidone Placebo)
Recruiting
- Bipolar I Disorder
- Iloperidone
- Iloperidone Placebo
-
Long Beach, California
- +2 more
Mar 24, 2021
Bipolar Disorder Trial in United States (Ziprasidone oral capsules)
Completed
- Bipolar Disorder
- Ziprasidone oral capsules
-
Scottsdale, Arizona
- +40 more
Mar 2, 2021
Duration of Untreated Manic Episodes on Clinical Outcome
Unknown status
- Patients Diagnosed With Bipolar Disorder ( Manic Episodes) and Delayed Diagnosis
- young mania rating scale
-
Assiut, EgyptAssiut university
Sep 19, 2020
Bipolar Depression Trial in Worldwide (Lumateperone, Placebo)
Bipolar Disorder Therapies
Completed
- Bipolar Disorder
- Lithium Carbonate
- +29 more
-
Albuquerque, New MexicoChristophe G Lambert
Sep 29, 2021
Bipolar Disorder Trial in United States (Ziprasidone oral capsules, oral capsules)
Completed
- Bipolar Disorder
- Ziprasidone oral capsules
- placebo oral capsules
-
Scottsdale, Arizona
- +49 more
Mar 2, 2021
Bipolar Disorder Trial in Ukraine, United States ( oral capsules, ziprasidone oral capsules)
Terminated
- Bipolar Disorder
- placebo oral capsules
- ziprasidone oral capsules
-
Dothan, Alabama
- +49 more
Jun 15, 2021
Depression, Bipolar I Disorder Trial in Worldwide (Cariprazine, Placebo)
Recruiting
- Depression
- Bipolar I Disorder
- Cariprazine
- Placebo
-
Bentonville, Arkansas
- +51 more
Aug 22, 2022
Bipolar Disorder Trial in Canada (Ziprasidone HCL (oral))
Terminated
- Bipolar Disorder
- Ziprasidone HCL (oral)
-
Calgary, Alberta, Canada
- +9 more
Mar 2, 2021
Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder Trial in United States (BXCL501, Matching Placebo)
Recruiting
- Agitation,Psychomotor
- +5 more
- BXCL501
- Matching Placebo
-
Little Rock, Arkansas
- +16 more
Jan 31, 2023